Malaria in Africa Is Not Destiny: How We Are Really Fighting It

By Lena Élyse Kovač

In the mental maps of many people in the West, malaria in Africa appears as a permanent landscape: mosquitoes, fever, and poverty.

This is a profound misconception.

Malaria is not an inevitable natural condition of the continent. It is the dynamic result of an encounter between a parasite, a vector, a favourable environment and—most importantly—fragile health systems and economic inequality.

Fighting malaria means acting on all these levels simultaneously.

1. A Many-Sided Enemy: Parasite, Mosquito, and Environment

Malaria is not a generic infection but a group of diseases caused by parasites of the Plasmodium genus, transmitted to humans through the bites of infected female Anopheles mosquitoes.

Across much of sub-Saharan Africa, Plasmodium falciparum, the most dangerous and deadly form of the parasite, predominates.

Any serious strategy must pursue three objectives at once:

Reduce contact between mosquitoes and people.
Reduce the parasite’s ability to survive, reproduce, and cause disease.
Reduce the environmental and social conditions that make transmission easier.

When efforts concentrate on only one of these levels—for example, distributing medicines without improving access to healthcare or living conditions—the resulting intervention is fragile. Its effects can easily be eroded by time, drug and insecticide resistance, disrupted supply chains, conflict, and economic crises.

2. Nets, Insecticides, and Housing: The First Line of Defence

The iconic image of the fight against malaria in Africa is an insecticide-treated mosquito net suspended above a bed.

This is not symbolic rhetoric. The systematic use of treated nets has prevented infections and saved lives across many regions.

These nets operate in two ways:

Physically, they create a barrier between the human body and mosquitoes that bite at night.
Chemically, their long-lasting insecticide kills or repels mosquitoes that come into contact with the net.

Alongside treated nets are other household and community interventions. These include improving the structure of homes by closing openings and installing screens, managing mosquito breeding sites where appropriate, improving drainage, and conducting indoor residual spraying in high-risk areas.

None of these measures is particularly spectacular.

Good public-health policy is often deliberately unspectacular. It consists of millions of small, repeated improvements rather than a single moment of genius.

3. Medicines: Treat Early and Reach Everyone

The other major front is pharmacological.

Standard treatment for uncomplicated P. falciparum malaria is generally based on artemisinin-based combination therapies, which rapidly reduce the number of parasites in the blood.

The crucial issue, however, is not simply possessing the medicine. It is ensuring that the right treatment reaches the patient in time.

This requires at least four conditions:

Rapid diagnosis: reliable tests must be available in remote communities, not only in major hospitals.
Access without prohibitive costs: no child should die of malaria because a family cannot afford diagnosis or treatment.
Reliable procurement and distribution: medicines and diagnostic supplies must be properly stored, monitored, and delivered to the last mile without repeated shortages.
Continuous training for frontline health workers: in many rural areas, they are the only functioning point of access to the health system.

There is also a risk familiar to anyone working in infectious disease: resistance.

Incorrect prescriptions, poor-quality medicines, and incomplete treatment can favour parasites that are less sensitive to existing drugs. Fighting malaria therefore also means resisting our tendency to deliver treatment inconsistently or to use powerful medicines without adequate diagnosis and supervision.

4. Vaccines and New Technologies: Promise and Limitations

The arrival of the first malaria vaccines was rightly described as a historic breakthrough.

But we must understand what these vaccines can and cannot do. They are not the total shield that many people imagine. They are tools that can:

Reduce episodes of clinical malaria.
Reduce the risk of severe disease and death among children.
Produce their greatest impact when combined with nets, diagnosis, effective medicines, and mosquito-control programmes.

Around vaccination, an entire constellation of innovations is developing:

New insecticides and next-generation nets designed to overcome mosquito resistance.
Digital surveillance systems combining clinical, climatic, geographic, and mobility data to identify emerging outbreaks.
Genetic techniques intended to reduce mosquito populations or make mosquitoes less capable of transmitting the parasite.
Improved diagnostics designed to detect parasite variants that may escape some conventional rapid tests.

Every time a new technology is introduced into a complex biological and social ecosystem, we must ask more than whether it works under controlled conditions.

We must also ask: How will it change human behaviour? What effects might it have on ecological relationships? Who will gain access first, and who will be left behind?

The history of malaria control is also a history of good intentions producing ambiguous results when they were not supported by systemic planning.

5. Poverty, Climate, and Politics: The Mosquitoes We Cannot See

There is a cruel temptation to treat malaria as a purely biological problem that can be solved in a laboratory.

In reality, every map of malaria in Africa is also a map of poverty, unequal access to healthcare, unmanaged urban growth, environmental disruption, and conflict.

Where health systems are fragile, diagnosis arrives late.
Where housing offers little protection, exposure to mosquitoes remains constant.
Where governance and funding are unstable, control programmes become irregular and difficult to monitor.
Where conflict displaces communities, prevention and treatment networks can collapse altogether.

A changing climate adds another layer of complexity. Temperature, rainfall, humidity, flooding, drought, and population displacement can alter the environments in which mosquitoes and parasites survive.

The effects will not be identical everywhere, and climate is not the only force shaping malaria transmission. But it can shift existing risk, create new areas of suitability, disrupt health services, and amplify vulnerabilities that are already present.

Fighting malaria in Africa therefore also requires abandoning the illusion that the planet’s climate can be destabilised without consequences for human health.

6. From “Fighting Malaria” to Building Systems

I am often asked: “Which single intervention works best against malaria?”

The most honest answer is that the question is wrong.

Malaria is not defeated through a single action. It is defeated through a system.

A system in which:

Physical prevention—treated nets, better housing, appropriate environmental management, and vector control—is part of ordinary public administration.
Diagnosis and treatment are rapid, affordable, geographically widespread, and consistently available.
Vaccination programmes form part of a long-term strategy rather than a one-time event organised for a ceremonial photograph.
Medicines, vaccines, tests, and protective equipment reach the communities that need them without recurrent shortages.
Data are collected, analysed, and shared so that interventions can be adjusted in near real time.
Drug and insecticide resistance are continuously monitored rather than discovered only after existing tools begin to fail.

Science can provide instruments, models, treatments, vaccines, and evidence of effectiveness.

But the decision to make malaria a chapter of history rather than a permanent chapter of the present is political, economic, and cultural.

There is no natural law declaring that a child born in Africa must face a greater risk of dying from malaria than a child born in Europe faces from severe influenza. That disparity is the result of collective choices, expressed through budgets, infrastructure, political priorities, and our willingness—or unwillingness—to look beyond the duration of a funding programme or an electoral cycle.

The good news is that we know how to fight malaria.

The bad news is that knowledge is not enough. We must also decide that the life of a child sleeping beneath an insecticide-treated net carries, within our system of values, the same weight as the life of someone sleeping beneath a duvet in a European capital.

Lena Élyse Kovač